Tickers: XCNQ:AREV, PINX:AREVF
Tags: #Healthcare
VANCOUVER, BC - TheNewswire - September 12, 2019 - AREV BRANDS INTERNATIONAL LTD. (CNSX:AREV.CN) (OTC:AREVF) ("AREV Brands") is pleased to announce that WOLLAMMO(TM) a BC Bud Depot product, is being packaged in preparation for sales after finalizing extensive testing on hemp and cannabis. WOLLAMMO(TM) is comprised of wollastonite a unique rare earth mineral composition from the Verticle Exploration St-Onge Deposit. The deposit is very high quality and clean compared to others in the world. The harvested plant biomass is being analyzed to ensure no heavy metals are present. While waiting for the final results AREV through BC Bud Depot is preparing to supply this fantastic solution to solve a problem the expanding cannabis and hemp cultivators have. The product will soon be available September 30 online at www.wollammo.com
AREV will enter into a Distribution Agreement with Vertical Exploration, whereby Vertical will supply its St-Onge wollastonite to AREV Brands for direct distribution to both small-scale craft growing operations and potentially larger-scale Health Canada approved companies directly involved in growing and processing cannabis and hemp.
Vertical's high quality wollastonite has been shown to be beneficial to cannabis plants in a variety of ways. In February 2019, Vertical announced the successful completion of Phase Three trials involving cannabis grown with wollastonite (CaSiO3) as a soil additive at BC Bud Depot's (BCBD) ACMPR-licenced Research and Development facilities in Vancouver, BC. In the Phase Three trials BCBD measured and recorded significant improvements in root mass, powdery mildew control and pest elimination. In every case the most optimal results occurred with an admixture rate of 10% to 15% wollastonite to the growth medium. Most notably, powdery mildew, the most common fungal blight to affect Cannabis sativa, was virtually undetectable with wollastonite admixture above 10%. An admixture above 10% wollastonite also correlated with sharp reductions in the presence of thrips and fungus gnats, insect pests with a sub-soil life phase in which the wollastonite crystals lacerate and impale their soft bodies. At a microscopic level, wollastonite's needle-like structure penetrates soft-bodied insect larvae and pupae, interrupting the life cycle without the use of pesticides.
WOLLAMMO(TM) has unique properties that allow it to break down into calcium, magnesium and silicon in a highly bio-available form that balances soil PH throughout the growth cycle - this allows the cannabis plants to uptake silicic acid and promotes strong cell walls that better resist insect feeding and spore penetration, supporting increased growth and elevated product yields. (see Vertical's February 5th, 2019 news release)
AREV Brands and Vertical believe there is a significant market opportunity for WOLLAMMO(TM), and that the anticipated distribution partnership will be lucrative for both companies.
Further details regarding the Distribution Agreement will be provided as soon as all terms of the Agreement have been finalized between AREV Brands and Vertical. This transaction is subject to the approval of the TSX Venture Exchange.
For further information, contact Mike Withrow, mike@AREVBrands.com 778-379-8551.
On behalf of the Board,
Mike Withrow
CEO & Director
ABOUT VERTICAL EXPLORATION
Vertical Exploration's mission is to identify, acquire, and advance high potential mining prospects located in North America for the benefit of its stakeholders. The Company's flagship St-Onge Wollastonite property is located in the Lac-Saint-Jean area in the Province of Quebec.
About AREV Brands International Ltd.
AREV Brands International Ltd. ("AREV") produces and delivers functional compounds and ingredients derived from verified genetics ran through its world-class extraction systems. AREV is revolutionizing the current delivery method of terpenes, cannabinoids and flavonoids. These premium ingredients and formulations are used in products targeted for sale in the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV innovates through extraction to produce extracts from specific selected plant and exude from trees that address 5 areas of health including Anxiety, Pain Management, Insomnia, Central Nervous System Disorders & Libido.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company's Management's Discussion and Analysis under the Company's profile on www.sedar.com.
Copyright (c) 2019 TheNewswire - All rights reserved.
